| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |